
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
Introduction Immunotherapy with immune checkpoint inhibitors (ICIs) has transformed treatment strategies for several cancer types but has historically lagged in breast cancer (BC).1 Advances in this field have primarily been seen in triple-negative breast …